Medicine
Cefazolin 3 g/150 mL injection
Cefazolin 3 g/150 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in a freezer capable of maintaining a temperature of -20°C (-4°F) or…
Key facts
- Active ingredient (INN)
- Cefazolin
- Brand
- Sold under the generic name
- Strength
- 3 g/150 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 6 bags of 150 mL
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store in a freezer capable of maintaining a temperature of -20°C (-4°F) or below. Thaw frozen container at room temperature 20°C to 25°C (68°F to 77°F) or under refrigeration 2°C to 8°C (36°F to 46°F). The thawed solution is stable for 30 days under refrigeration (5°C/41°F) or 48 hours at 25°C/77°F.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DB04 Cefazolin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 May 2024
- Identifiers
- RxCUI 1665050, 1665060, 2630753DailyMed set ID d91a8d13-99a0-4d87-88dc-71cbd37922b4NDC 0338-0096Application NDA207131
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 bag in 1 carton / 150 mL in 1 bag | 0338-0096-06 | Baxter Healthcare | 31 May 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 October 1973 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefazolin
Clinical summary
Cefazolin is a cephalosporin antibacterial indicated for treatment of infections caused by susceptible isolates of the designated microorganisms in adult and pediatric patients for whom appropriate dosing with this formulation can be achieved, among other approved uses. MedsAcross supplies Cefazolin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefazolinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefazolin Sodium prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Cefazolin 3 g/150 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.